TY - JOUR T1 - Education and treatment adherence during the COVID-19 pandemic. Response to: ‘Adherence to medication in patients with rheumatic diseases during COVID-19 pandemic’ by Khabbazi <em>et al</em> JF - Annals of the Rheumatic Diseases JO - Ann Rheum Dis DO - 10.1136/annrheumdis-2020-218791 SP - annrheumdis-2020-218791 AU - Rita Angélica Pineda-Sic AU - Griselda Serna-Peña AU - Jesus Alberto Cardenas-de la Garza AU - Sergio A Torres-Castillo AU - Dionicio Angel Galarza-Delgado AU - Diana Elsa Flores-Alvarado Y1 - 2020/09/07 UR - http://ard.bmj.com/content/early/2020/09/06/annrheumdis-2020-218791.abstract N2 - With great interest, we read the study of Dr Khabbazi et al1 regarding treatment adherence in patients with inflammatory rheumatic diseases during the COVID-19 pandemic in the East Azarbaijan province of Iran. They conducted telephone interviews to 1324 patients and inquired about treatment adherence behaviours during 2 weeks from July 2020. Of the 858 patients included in the final analysis, non-adherence was reported by 6.5% of the patients (defined by the group as ≥20% change in the dose or frequency of medications). In accordance to previous studies,2 … ER -